Genmab A/S (ETR:GE9)

Genmab Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,237	12,713	18,886	25,843	23,141	21,644
Market Cap Growth	15.17%	-32.69%	-26.92%	11.68%	6.92%	67.76%
Enterprise Value	12,449	10,523	15,300	22,730	20,679	19,343
Last Close Price	246.90	-	331.00	331.00	343.00	-
PE Ratio	11.29	12.09	32.35	35.26	58.19	33.86
PS Ratio	4.65	4.40	8.55	13.25	20.44	15.93
PB Ratio	3.11	2.58	4.45	7.05	7.75	8.43
P/TBV Ratio	4.90	4.35	4.47	7.08	7.84	8.58
P/FCF Ratio	13.46	12.50	20.07	53.47	87.08	26.30
P/OCF Ratio	13.06	12.20	19.08	49.14	77.23	25.04
EV/Sales Ratio	3.80	3.65	6.92	11.66	18.27	14.24
EV/EBITDA Ratio	9.80	10.62	20.63	25.79	48.86	22.00
EV/EBIT Ratio	10.30	11.09	21.43	26.98	52.07	22.81
EV/FCF Ratio	11.00	10.35	16.26	47.03	77.81	23.50
Debt / Equity Ratio	0.03	0.03	0.02	0.02	0.02	0.02
Debt / EBITDA Ratio	0.10	0.14	0.14	0.09	0.14	0.05
Debt / FCF Ratio	0.11	0.14	0.11	0.17	0.22	0.05
Asset Turnover	0.58	0.53	0.50	0.53	0.37	0.56
Inventory Turnover	17.23	16.56	-	-	-	-
Quick Ratio	6.02	5.24	13.32	15.48	14.50	15.00
Current Ratio	6.03	5.25	13.34	15.48	14.50	15.00
Return on Equity (ROE)	29.41%	22.97%	14.78%	22.04%	14.31%	28.69%
Return on Assets (ROA)	13.38%	10.91%	10.17%	14.31%	8.06%	21.75%
Return on Capital (ROIC)	16.02%	12.62%	11.04%	15.51%	8.78%	23.44%
Return on Capital Employed (ROCE)	22.60%	17.50%	16.20%	22.10%	12.80%	31.70%
Earnings Yield	8.86%	8.27%	3.09%	2.84%	1.72%	2.95%
FCF Yield	7.43%	8.00%	4.98%	1.87%	1.15%	3.80%
Buyback Yield / Dilution	3.12%	1.94%	0.14%	0.06%	-0.24%	-3.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.